We are live on ! Find out more
VDI

Vaughan David Investments Portfolio holdings

AUM $4.73B
1-Year Est. Return 19.55%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+19.55%
3 Year Est. Return
+59.13%
5 Year Est. Return
+79.37%
10 Year Est. Return
+243.14%
AUM
$4.6B
AUM Growth
-$38.5M
Cap. Flow
-$21.5M
Cap. Flow %
-0.47%
Top 10 Hldgs %
20.7%
Holding
235
New
8
Increased
71
Reduced
96
Closed
10

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$35.5M
2
D icon
Dominion Energy
D
+$23.6M
3
AVGO icon
Broadcom
AVGO
+$13.2M
4
ORCL icon
Oracle
ORCL
+$12.9M
5
LRCX icon
Lam Research
LRCX
+$5.37M

Sector Composition

Rank Sector Weight
1 Financials 19.4%
2 Technology 15.1%
3 Utilities 13.83%
4 Healthcare 12.56%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
226
D.R. Horton
DHI
$42.3B
-1,200
Closed -$203K
FSEP icon
227
FT Vest US Equity Buffer ETF September
FSEP
$1.23B
-4,913
Closed -$248K
IAU icon
228
iShares Gold Trust
IAU
$67.5B
-4,100
Closed -$298K
INTU icon
229
Intuit
INTU
$89B
-297
Closed -$203K
NFG icon
230
National Fuel Gas
NFG
$7.65B
-2,830
Closed -$261K
SLV icon
231
iShares Silver Trust
SLV
$30.7B
-14,600
Closed -$619K
VOO icon
232
Vanguard S&P 500 ETF
VOO
$1.01T
-391
Closed -$239K
VST icon
233
Vistra
VST
$47.4B
-1,236
Closed -$242K
WOR icon
234
Worthington Enterprises
WOR
$2.86B
-3,950
Closed -$219K

Similar funds

Vaughan David Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Vaughan David Investments held 235 positions worth $4.6B, down 0.83% from $4.64B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Vaughan David Investments's Q4 2025 filing shows 8 new, 71 increased, 96 reduced and 10 closed positions. Its largest new stake was Gilead Sciences: 275,391 shares worth $33.8M. The largest sale was Amgen, an estimated $35.5M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Utilities.

  • Vaughan David Investments's largest Q4 2025 buy was Gilead Sciences: 275,391 shares worth $33.8M.
  • Vaughan David Investments added most to Progressive in Q4 2025, an estimated $25.1M increase.
  • Vaughan David Investments's biggest Q4 2025 reduction was Amgen, cutting an estimated $35.5M.
  • Vaughan David Investments fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $4.12M.
  • Vaughan David Investments's ten largest holdings make up 21% of its $4.6B portfolio in Q4 2025.
  • Vaughan David Investments opened 8 new positions and closed 10 in Q4 2025.
  • Vaughan David Investments's portfolio value fell 0.83% quarter-over-quarter to $4.6B.

Based on Vaughan David Investments's 13F filing for Q4 2025, filed 12 Feb 2026.